Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23909501)

1.

Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis.

Franz C, Hoffmann K, Hinz U, Singer R, Hund E, Gotthardt DN, Ganten T, Kristen AV, Hegenbart U, Schönland S, Hinderhofer K, Büchler MW, Schemmer P.

Clin Transplant. 2013 Jul-Aug;27 Suppl 25:40-8. doi: 10.1111/ctr.12193.

PMID:
23909501
2.

Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.

Singer R, Mehrabi A, Schemmer P, Kashfi A, Hegenbart U, Goldschmidt H, Schönland S, Kristen A, Dengler T, Müller-Schilling M, Sauer P, Dogan A, Hund E, Helmke B, Schnabel P, Altland K, Linke R, Friess H, Schmidt J, Büchler MW, Kraus TW.

Transplantation. 2005 Sep 27;80(1 Suppl):S156-9.

PMID:
16286896
3.

Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.

Bittencourt PL, Couto CA, Farias AQ, Marchiori P, Bosco Massarollo PC, Mies S.

Liver Transpl. 2002 Jan;8(1):34-9.

4.
5.

Hereditary lysozyme amyloidosis -- phenotypic heterogeneity and the role of solid organ transplantation.

Sattianayagam PT, Gibbs SD, Rowczenio D, Pinney JH, Wechalekar AD, Gilbertson JA, Hawkins PN, Lachmann HJ, Gillmore JD.

J Intern Med. 2012 Jul;272(1):36-44. doi: 10.1111/j.1365-2796.2011.02470.x. Epub 2011 Nov 15.

PMID:
21988333
6.

Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation.

Ohya Y, Okamoto S, Tasaki M, Ueda M, Jono H, Obayashi K, Takeda K, Okajima H, Asonuma K, Hara R, Tanihara H, Ando Y, Inomata Y.

Surg Today. 2011 Sep;41(9):1211-8. doi: 10.1007/s00595-010-4488-5. Epub 2011 Aug 26.

PMID:
21874417
7.

Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years.

Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, Söderdahl G, Wikström L, Ando Y, Suhr OB, Ericzon BG.

Am J Transplant. 2007 Nov;7(11):2597-604. Epub 2007 Sep 14.

8.

Outcome of liver transplantation for familial amyloidotic polyneuropathy.

Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V.

Liver Transpl. 2003 Dec;9(12):1273-80.

9.

Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.

Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, Samuel D, Merlet P, Syrota A, Slama MS, Le Guludec D.

Medicine (Baltimore). 2006 Jul;85(4):229-38.

PMID:
16862048
10.

Organ transplantation in hereditary apolipoprotein AI amyloidosis.

Gillmore JD, Stangou AJ, Lachmann HJ, Goodman HJ, Wechalekar AD, Acheson J, Tennent GA, Bybee A, Gilbertson J, Rowczenio D, O'Grady J, Heaton ND, Pepys MB, Hawkins PN.

Am J Transplant. 2006 Oct;6(10):2342-7. Epub 2006 Aug 21.

11.

The impact of obesity as determined by modified body mass index on long-term outcome after liver transplantation: Canadian single-center experience.

Tanaka T, Renner EL, Selzner N, Therapondos G, Lilly LB.

Transplant Proc. 2013 Jul-Aug;45(6):2288-94. doi: 10.1016/j.transproceed.2012.11.009.

PMID:
23953540
12.

Liver transplantation for familial amyloidotic polyneuropathy in Australia.

Nishino M, Tagaya N, Lynch SV, Steadman C, Balderson GA, Strong RW.

J Hepatobiliary Pancreat Surg. 2000;7(3):312-5.

PMID:
10982632
13.

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.

Barreiros AP, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Schäfers HJ, Galle PR, Otto G.

Liver Transpl. 2010 Mar;16(3):314-23. doi: 10.1002/lt.21996.

14.

Orthotopic liver transplantation for hereditary fibrinogen amyloidosis.

Zeldenrust S, Gertz M, Uemichi T, Björnsson J, Wiesner R, Schwab T, Benson M.

Transplantation. 2003 Feb 27;75(4):560-1.

PMID:
12605128
15.

[Treatment of familial amyloid polyneuropathy].

Adams D, Samuel D, Slama M.

Presse Med. 2012 Sep;41(9 Pt 1):793-806. doi: 10.1016/j.lpm.2011.11.027. Epub 2012 Feb 16. French.

PMID:
22341949
16.

Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center.

Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Cescon M, Grazi GL, Salvi F, Magelli C, Grigioni F, Arpesella G, Martinelli G, Cavallari A.

Transplant Proc. 2004 Apr;36(3):645-7.

PMID:
15110620
17.

Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients.

Suhr OB, Holmgren G, Steen L, Wikström L, Norden G, Friman S, Duraj FF, Groth CG, Ericzon BG.

Transplantation. 1995 Nov 15;60(9):933-8.

PMID:
7491696
18.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2012 Jun;18(6):716-26. doi: 10.1002/lt.23411.

19.

Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland.

Traynor CA, Tighe D, O'Brien FJ, Leavey SF, Dorman AM, Denton MD, Magee C, Conlon PJ.

Nephrology (Carlton). 2013 Aug;18(8):549-54. doi: 10.1111/nep.12108.

PMID:
23730806
20.

Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy.

Nelson LM, Penninga L, Sander K, Hansen PB, Villadsen GE, Rasmussen A, Gustafsson F.

Clin Transplant. 2013 Mar-Apr;27(2):203-9. doi: 10.1111/ctr.12053. Epub 2012 Dec 27.

PMID:
23278526
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk